Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry. - Surcinelli A; Kalincik T; Roos I; D'Amico E; Lechner-Scott J; Ozakbas S; Hradilek P; Horáková D; Vachova M; Panzera I; Ruzza S; Piscaglia MG; et al. (Therapeutic advances in neurological disorders, 2026)